.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,501,817

« Back to Dashboard

Details for Patent: 8,501,817

Title:Stabilized compositions of alkylating agents and methods of using same
Abstract: A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: an alkylating agent such as, for example, a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the alkylating agent is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of the alkylating agent to the affected skin, wherein the alkylating agent is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol.
Inventor(s): Alonso; Robert (Rye, NH), Walker; Barry R. (Bryn Mawr, PA), Crooks; Peter A. (Nicholasville, KY)
Assignee: Ceptaris Therapeutics, Inc. (Malvern, PA)
Filing Date:Mar 11, 2009
Application Number:12/401,812
Claims:1. A composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier, wherein the non-aqueous vehicle or carrier comprises between about 15% and about 60% by weight of a pharmaceutically acceptable excipient, wherein the Nitrogen Mustard is represented by the following structures: ##STR00019## wherein each R.sub.1, R.sub.2, R.sub.3 . . . R.sub.34 (R.sub.1-R.sub.34) is independently selected from the group consisting of H, a linear alkyl group having 1-6 carbon atoms, a branched alkyl group having 2-12 carbon atoms, a cycloalkyl group having 3-17 carbon atoms, a fluorinated linear alkyl group having 2-12 carbon atoms, a fluorinated branched alkyl group having 2-12 carbon atoms, a fluorinated cycloalkyl group having 3-17 carbon atoms, aryl groups, aralkyl groups, alkaryl groups, cycloalkyl groups, bicycloalkyl groups, alkenyl groups, alkalkenyl groups, alkenylalkyl groups, alkynyl groups, alkalkynyl groups, alkynylalkyl groups, trifluoropropyl groups, cyanopropyl groups, acryloyl groups, arylacryloyl groups, acryloylaryl groups, alkylacyl groups, arylacyl groups, alkylenylacyl groups and alkynylacyl groups, wherein n is 1-3, wherein p is 0-2, wherein n +P<3, wherein any two R.sub.1-R.sub.34 in the same molecule may be linked to form a three-to eight-membered cyclic group, wherein the pharmaceutically acceptable excipient is 2-(2-ethoxyethoxy) ethanol, and wherein when the composition is applied topically to the skin, there is no clinically significant systemic absorption of the topically applied Nitrogen Mustard.

2. The composition of claim 1, wherein an ingredient of the non-aqueous vehicle or carrier is selected from the group consisting of, Hydroxypropylcellulose, buffer gel, Menthol Crystals USP5, Butylated Hydroxytoluene NF, Glycerin USP, Edetate Disodium USP, Decyl Methyl Sulfoxide, Kris-Ester 236, polyethylene glycol (PEG), ethylene glycol (EG), polypropylene glycol (PPG), propylene glycol (PG), diethylene glycol monosubstituted ether (DGMSE), HOCH.sub.2CH.sub.2OCH.sub.2CH.sub.2OR.sub.79 , wherein R.sub.79 is selected from the group consisting of a linear alkyl group having 1-6 carbon atoms, a branched alkyl group having 2-12 carbon atoms, a cycloalkyl group having 3-17 carbon atoms, a fluorinated linear alkyl group having 2-12 carbon atoms, a fluorinated branched alkyl group having 2-12 carbon atoms, a fluorinated cycloalkyl group having 3-17 carbon atoms, an aryl group, an aralkyl group, an alkaryl group, a cycloalkyl group, a bicycloalkyl group, an alkenyl group, an alkalkenyl group, an alkenylalkyl group, an alkynyl group, an alkalkynyl group, an alkynylalkyl group, a trifluoropropyl group, a cyanopropyl group, an acryloyl group, an arylacryloyl group, an acryloylaryl group, an alkylacyl group, an arylacyl group, an alkylenylacyl group, an alkynylacyl group, and combinations thereof.

3. The composition of claim 1, wherein the non-aqueous vehicle or carrier comprises propylene glycol USP.

4. The composition of claim 1, further comprising: Hydroxypropylcellulose, Menthol Crystals USP, Butylated Hydroxytoluene NF, Glycerin USP, Edetate Disodium USP, Decyl Methyl Sulfoxide, or Kris-Ester 236, or any combination thereof.

5. The composition of claim 1, comprising the HX salt of the Nitrogen Mustard, wherein the HX salt of the Nitrogen Mustard is Nitrogen Mustard.HCl, Nitrogen Mustard.HNO.sub.3, Nitrogen Mustard.H.sub.2SO.sub.4, Nitrogen Mustard.HBr, Nitrogen Mustard.HI, or any combination thereof.

6. The composition of claim 1, comprising from about 0.0001 to about 2.0 percent by weight of the Nitrogen Mustard or its HX salt.

7. The composition of claim 1, comprising from about 0.015 to about 0.030 percent by weight of the Nitrogen Mustard of its HX salt.

8. The composition of claim 1, comprising from about 0.01 to about 0.04 percent by weight of the Nitrogen Mustard or its HX salt.

9. The composition of claim 1, comprising the Nitrogen Mustard.

10. The composition of claim 1, comprising the HX salt of the Nitrogen Mustard.

11. The composition of claim 1, wherein the clause: when the composition is applied topically to the skin, there is no clinically significant systemic absorption of the topically applied Nitrogen Mustard; means there is 0% systemic toxicities.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc